Telephone: 507-266-1586. Fax: 507-266-2810
Mycophenolate mofetil combination therapy improves long-term outcomes after liver transplantation in patients with and without hepatitis C
Version of Record online: 22 JUN 2005
Copyright © 2005 American Association for the Study of Liver Diseases
Volume 11, Issue 7, pages 750–759, July 2005
How to Cite
Wiesner, R. H., Shorr, J. S., Steffen, B. J., Chu, A. H., Gordon, R. D. and Lake, J. R. (2005), Mycophenolate mofetil combination therapy improves long-term outcomes after liver transplantation in patients with and without hepatitis C. Liver Transpl, 11: 750–759. doi: 10.1002/lt.20453
- Issue online: 22 JUN 2005
- Version of Record online: 22 JUN 2005
- 1Department of Health and Human Services. 2003 Annual Report of the U.S. Organ Procurement and Transplantation Network and the Scientific Registry of Transplant Recipients: Transplant Data 1993–2002. Rockville, Md: Health Resources and Services Administration, Office of Special Programs, Division of Transplantation. Richmond, Va: United Network for Organ Sharing. Ann Arbor, Mich: University Renal Research and Education Association.
- 2A randomized double-blind comparative study of mycophenolate mofetil and azathioprine in combination with cyclosporine and corticosteroids in primary liver transplant recipients. Liver Transpl 2001; 7(5): 442–450., , , , , , et al.
- 9International Liver Transplantation Society Expert Panel. Report of the First International Liver Transplantation Expert Panel Consensus Conference of Liver Transplantation and Hepatitis C. Liver Transpl 2003; 9(11 suppl 3 ): S1–S9., , , and the